Our results greatly diverged from a recent study using a similar approach for OTI CD8+ T cell in vivo priming in the context of LCMV or Listeria monocytogenes infection, where presence of these pathogens did not inhibit and even improved the avidity of cognate OTI cells [28]. The gene discussed is CD8A; the disease is listeriosis.